Sandoz Recalls Generic Zantac in US in Wake of Sales Halt Sandoz Recalls Generic Zantac in US in Wake of Sales Halt

The recall of Sandoz ranitidine 150 mg and 300 mg capsules includes all quantities and lots of unexpired product and follows confirmed contamination with a likely human carcinogen in some product batches.News Alerts
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news